Posizioni attive di Katherine Sacksteder
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
BeneVir Biopharm, Inc.
 BeneVir Biopharm, Inc. BiotechnologyHealth Technology BeneVir Biopharm, Inc. develops oncolytic immunotherapies software for advanced solid tumors. It offers oncolytic immunotherapy, that attacks and kill cancer cells. The company was founded by Katherine Sacksteder, Matthew Charles Mulvey and Ian Mohr in 2011 and is headquartered in Rockville, MD. | Direttore operativo | 01/01/2011 | - |
| Fondatore | 01/01/2011 | - |
Storia della carriera di Katherine Sacksteder
Precedenti posizioni note di Katherine Sacksteder
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Sequella, Inc.
 Sequella, Inc. Pharmaceuticals: MajorHealth Technology Sequella, Inc. develops antibiotic drugs resistant to bacterial, fungal, and parasitic infections. It offers product for Mycobacterium tuberculosis, Helicobacter pylori, Clostridium difficile, Nontuberculous mycobacteria, Trypanosomes, and fungal infections. The company was founded by Carol A. Nacy and Leo Einck in 1997 and is headquartered in Rockville, MD. | Corporate Officer/Principal | - | - |
Statistiche
Distribuzione geografica
| Stati Uniti | 3 |
Posizioni
| Corporate Officer/Principal | 1 |
| Chief Operating Officer | 1 |
| Founder | 1 |
Settori
| Health Technology | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 2 |
|---|---|
Sequella, Inc.
Sequella, Inc. Pharmaceuticals: MajorHealth Technology Sequella, Inc. develops antibiotic drugs resistant to bacterial, fungal, and parasitic infections. It offers product for Mycobacterium tuberculosis, Helicobacter pylori, Clostridium difficile, Nontuberculous mycobacteria, Trypanosomes, and fungal infections. The company was founded by Carol A. Nacy and Leo Einck in 1997 and is headquartered in Rockville, MD. | Health Technology |
BeneVir Biopharm, Inc.
BeneVir Biopharm, Inc. BiotechnologyHealth Technology BeneVir Biopharm, Inc. develops oncolytic immunotherapies software for advanced solid tumors. It offers oncolytic immunotherapy, that attacks and kill cancer cells. The company was founded by Katherine Sacksteder, Matthew Charles Mulvey and Ian Mohr in 2011 and is headquartered in Rockville, MD. | Health Technology |
- Borsa valori
- Insiders
- Katherine Sacksteder
- Esperienza
